Insmed
INSM
#969
Rank
A$35.10 B
Marketcap
A$160.02
Share price
0.89%
Change (1 day)
-44.74%
Change (1 year)

Earnings for Insmed (INSM)

Earnings in 2026 (TTM): -A$1.19 Billion

According to Insmed's latest financial reports the company's current earnings are A$1.13 Billion. In 2025 the company made an earning of -A$1.7 Billion a decrease over its 2024 earnings that were of -A$1.18 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Insmed from 2000 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -A$1.19 Billion-30.2%
2025 -A$1.7 Billion43.91%
2024 -A$1.18 Billion23.71%
2023 -A$0.96 Billion45.77%
2022 -A$0.66 Billion15.83%
2021 -A$0.57 Billion50.19%
2020 -A$0.38 Billion16.4%
2019 -A$0.33 Billion-23.9%
2018 -A$0.43 Billion59.35%
2017 -A$0.27 Billion8.52%
2016 -A$0.25 Billion47.25%
2015 -A$0.17 Billion34.53%
2014 -A$0.13 Billion58.83%
2013 -A$78.01 Million35.14%
2012 -A$57.73 Million-31.92%
2011 -A$84.8 Million854.92%
2010 -A$8.88 Million-105.22%
2009 A$0.17 B-905.06%
2008 -A$21.12 Million-27.31%
2007 -A$29.06 Million-62.41%
2006 -A$77.29 Million98.19%
2005 -A$39 Million0.03%
2004 -A$38.99 Million159.07%
2003 -A$15.05 Million-69.31%
2002 -A$49.03 Million
2000 -A$44.21 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Novartis
NVS
A$22.06 B-2,056.64%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Gilead Sciences
GILD
-A$2.78 Billion 146.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
A$7.16 B-735.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
-A$0.19 Billion-83.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
-A$33.04 Million-97.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Array Technologies
ARRY
-A$73.42 Million-93.49%๐Ÿ‡บ๐Ÿ‡ธ USA